US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Prescription Drugs Market Research Reports & Industry Analysis

RSS Feeds

Prescription Drugs Industry Research & Market Reports

  2    4  5  6  7  8  9  10  
Hungary Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
... risk team also sees potential headwindsto spending growth, namely Hungary's excessive government deficits. Under Deficit Procedure rules,Hungary will be forced to trim back its fiscal spending, with negative implications for healthcare. Pricingpressures and slow uptake ...  |  read more...
USD 1,295
Jordan Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
... stillprevalent in the market, although steps are being taken to combat this, such as the Jordan Food and DrugAdministration (JFDA)'s recent conference. Although we forecast growth for both the pharmaceutical andhealthcare sectors, our outlook is ...  |  read more...
USD 1,295
Romania Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
... in theconsumer outlook and the country's macroeconomic prospects, in line with the views of our Country Riskteam. Provided unemployment continues to pare down and economic growth continues, the pharmaceuticalmarket will continue on its current growth ...  |  read more...
USD 1,295
Cote d'Ivoire Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
... lack of policy enforcement and approvalsexpediency and a generally weak business setting. The healthcare market remains underdeveloped, whilethe burden of communicable diseases is considerable. Nevertheless, we have a more positive outlook foreconomic and pharmaceutical growth ...  |  read more...
USD 1,295
Taiwan Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
... Given theincreasing demand for health services from the ageing population, Taiwan will continue to limit theescalation of drug prices, which will negatively impact the pharmaceutical market's growth potential. Inparticular demand for long-term care and welfare ...  |  read more...
USD 1,295
Brazil Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
... aresignificant revenue-generating opportunities for drugmakers, medical device companies and healthcareservice providers. However, multinationals will continue to face increasing government intervention anddomestic competition. Headline Expenditure Projections Pharmaceuticals: BRL57.0bn (USD26.4bn) in 2013 to BRL62.0bn (USD26.6bn) in 2014; ...  |  read more...
USD 1,295
Canada Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
... regulatory authority also encourages pharmaceutical companies to invest in research anddevelopment. However, cost containment policies in the public healthcare sector will continue to putpressure on Canada's medicine prices. Headline Expenditure Projections Pharmaceuticals: CAD25.6bn (USD24.9bn) in ...  |  read more...
USD 1,295
Bahrain Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
... to only moderategrowth in the short term. Longer term, the country's ageing population, increasing chronic diseases burdenand robust economic growth will drive medicine demand; however, further medicine price cuts, lower-thanexpectedoil prices in coming years and ...  |  read more...
USD 1,295
Italy Pharmaceuticals and Healthcare - Report Q4 2014
9/3/2014 | published by: Business Monitor International
... prescription drugmakers, patients and pharmacies in the country. Thesuccess of the implemented policies may encourage the enforcement of further cost-containment measurestargeting the pharmaceutical industry, particularly as the government is focused on slashing publichealthcare costs. The ...  |  read more...
USD 1,295
New Zealand Pharmaceuticals and Healthcare - Report Q4 2014
9/3/2014 | published by: Business Monitor International
... pharmaceutical spending. Between2013 and 2018, BMI forecasts that pharmaceutical sales in New Zealand will grow at a local compoundannual growth rate (CAGR) of 2.7% (-0.5% in US dollar terms). Headline Expenditure Forecasts Pharmaceuticals: NZD1.42bn (USD1.17bn) ...  |  read more...
USD 1,295
Singapore Pharmaceuticals and Healthcare - Report Q4 2014
9/3/2014 | published by: Business Monitor International
... of pharmaceuticals over the long term. In addition, the impending launch of the Association ofSouth East Asian Nations Community in 2015 will increase Singapore's attractiveness to foreignpharmaceutical firms. Headline Expenditure Projections Pharmaceuticals: SGD990mn (USD790mn) in ...  |  read more...
USD 1,295
Sweden Pharmaceuticals and Healthcare - Report Q4 2014
9/3/2014 | published by: Business Monitor International
... Restricting innovative drugmaker revenue streams while increasing the use of affordable generic medicinesoffers a partial solution to the problem, as does encouraging the consumption of older medicines overnewer, higher-value medicines. Headline Expenditure Projections Pharmaceuticals: SEK36.28bn ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Hong Kong Q4 2014
8/27/2014 | published by: Business Monitor International
... proximity from China will also allowcompanies to expand into the world's largest emerging market. Headline Expenditure Projections Pharmaceuticals: HKD11.24bn (USD1.45bn) in 2013 to HKD12.12bn (USD1.56bn) in 2014; +7.8% inlocal currency terms and US dollar terms. ...  |  read more...
USD 1,295
Algeria Pharmaceuticals and Healthcare Report - Q4 2014
8/20/2014 | published by: Business Monitor International
... as a strategic sector in the economy, will continue throughout Q414. A new memorandum of understanding between Pharmaceutical Research and Manufacturers of America(PhRMA) and Algeria's government indicates additional steps towards encouraging foreign directinvestment (FDI), and ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Japan Q4 2014
8/27/2014 | published by: Business Monitor International
... consumption tax inJapan was raised from 5% to 8% and the biennial pharmaceutical price cut was implemented. According tothe Central Social Insurance Medical Committee, the 2014 pharmaceutical price revision means that therewill be, on average, ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Namibia Q4 2014
8/27/2014 | published by: Business Monitor International
... approving a NAD400mn spendingallowance for the Ministry of Health and Social Services, to allow it to buy the drugs it needs. However, webelieve that healthcare access for many of the country's citizens is likely to ...  |  read more...
USD 1,295
Croatia Pharmaceuticals and Healthcare Report - Q4 2014
8/20/2014 | published by: Business Monitor International
... withdrawals expected andthe HZZO braced for revolt from pharmacies and wholesalers. We forecast weak pharmaceutical marketgrowth over the next decade, in light of Croatia's acceding to EU pressure to rein in its budget deficit. Liquidity ...  |  read more...
USD 1,295
Mexico Pharmaceuticals and Healthcare Report - Q4 2014
8/20/2014 | published by: Business Monitor International
... Mexico will continueto undermine revenue-generating opportunities for innovative drugmakers. However, over the long term,healthier fiscal revenue due to energy reform will encourage the Mexican government to further increasepublic spending on medical services and improve national ...  |  read more...
USD 1,295
Zambia Pharmaceuticals and Healthcare Report - Q4 2014
8/20/2014 | published by: Business Monitor International
... to serve the district of Chienge. This,along with ongoing governmental training initiatives aimed at improving the skills of Zambian healthcareprofessionals, is likely to attract talent to the country. That said, speculation over President Sata's ill ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - South Korea Q4 2014
8/27/2014 | published by: Business Monitor International
... pharmaceuticalcosts in particular. Consequently, domestic companies will have to expand beyond South Korea to maintaingrowth. Headline Expenditure Projections Pharmaceuticals: KRW16,106.7bn (USD14.71bn) in 2013 to KRW16,590.4bn (USD15.80bn) in 2014;+3.0% in local currency terms and +7.4% in ...  |  read more...
USD 1,295
Colombia Pharmaceuticals and Healthcare - Report Q4 2014
9/3/2014 | published by: Business Monitor International
... administration has been successful inlimiting medicine price increases, financial problems will to plague the Colombian insurance system ifstructural issues are not addressed. Headline Expenditure Projections Pharmaceuticals: COP8,126bn (USD4.35bn) in 2013 to COP8,686bn (USD4.44bn) in 2014; ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Angola Q4 2014
8/27/2014 | published by: Business Monitor International
... attracting external revenues. Angola'shigh burden of communicable disease, such as measles and malaria, will mean that the demand forvaccines remain high. However, the country's pharmaceutical and healthcare market is greatly affected byits difficult operating environment, ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Argentina Q4 2014
8/27/2014 | published by: Business Monitor International
... erode the growth ofthe country's pharmaceutical market. More foreign pharmaceutical companies will cease their localoperations, if the hostile business environment is worsened. Headline Expenditure Projections Pharmaceuticals: ARS39.30bn (USD7.18 bn) in 2013 to ARS50.10bn (USD6.04bn) in ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Colombia Q4 2014
8/27/2014 | published by: Business Monitor International
... bioequivalence regulationswill also undermine sale growth posted by branded generic drugmakers. However, Colombia's relativelyadvanced drug reimbursement system will still offer revenue-generating opportunities for multinationals incomparison with other second-tier Latin American pharmaceutical markets. Headline Expenditure Projections ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Mozambique Q4 2014
8/27/2014 | published by: Business Monitor International
... medicines and healthcare facilities. Vaccination programs and trials are being put into place, particularly for malaria and HIV immunisation,to help combat the county's high burden of disease. However, Mozambique's pharmaceutical market suffersfrom an abundance of ...  |  read more...
USD 1,295
  2    4  5  6  7  8  9  10